MPM Capital

Portfolio · 1

Chiasma

Oral Therapeutic Options for Patients with Rare Diseases

3 rounds $147.5M committed Latest: 2015-02

Investment activity

1 portfolio exit on record.

Q&A

What is MPM Capital's primary sector focus for investments?

MPM Capital primarily focuses on the Health Tech & Life Sciences sector, with all of its portfolio companies and exits concentrated in this area.

Can you name a notable exit for MPM Capital?

MPM Capital had a notable exit with Chiasma, which went public on NASDAQ in July 2015 with a valuation of $562M.

What is the typical investment range for MPM Capital?

MPM Capital's investment range is typically between $33.5M and $70M.

Which funding stages does MPM Capital typically participate in?

MPM Capital has participated in C Round, D Round, and E Round funding stages.

When was MPM Capital's most recent investment round activity?

MPM Capital's most recent investment round activity occurred in February 2015.

What is the most recent exit event recorded for MPM Capital?

The most recent exit event recorded for MPM Capital was in July 2015, when Chiasma went public.

How many portfolio companies does MPM Capital have in the Health Tech & Life Sciences sector?

MPM Capital has one portfolio company, Chiasma, in the Health Tech & Life Sciences sector.